Kontafarma China Holdings Ltd (1312.HK) HKSE
0.03
+0.001(+3.57%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.03
+0.001(+3.57%)
Currency In HKD
Sector
Basic Materials
Industry
Construction Materials
Employees
714
First IPO Date
January 18, 2012
| Name | Title | Pay | Year Born |
| Zixiu Guo | Financial Controller & Executive Director | 105,000 | N/A |
| Feifei Wang | Executive Chairman & President | 0 | N/A |
| Jiankun Liu | Executive Director | 0 | N/A |
| Jie Zhang | Chief Operating Officer | 0 | N/A |
| Linna Qiao | Vice President & Executive Director | 0 | N/A |
| Lok Tung Chan | Company Secretary | 0 | N/A |
Kontafarma China Holdings Ltd. engages in the manufacture and sale of cement. It operates through the following segments: Pharmaceutical and Fitness Business. The Pharmaceutical Business segment involves in manufacture and sales of prescription drugs and laboratory related products. The Fitness Business segment includes the operation of fitness centers and provide consultation services for fitness and health activities and operate the franchise business for royalty fee income. The company was founded on March 21, 2011 and is headquartered in Hong Kong.